[Aldehyde dehydrogenase with hepatocellular carcinoma].

W J Wang1, Y H Gao1

  • 1Department of Hepatology, the First Hospital of Jilin University, Changchun 130021, China.

Summary

Defective acetaldehyde dehydrogenase 2 (ALDH2) affects liver metabolism in 8% of the global population. ALDH2 is crucial for liver cancer risk, pathogenesis, and prognosis, presenting a potential therapeutic target.